Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RESET-IT Pilot Study: Intermittent Insulin for Type 2 Diabetes
NCT01755468Phase 3Completed
- Sponsor
- Mount Sinai Hospital
- Start
- Apr 2013
- Primary completion
- Oct 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of insulin glargine, insulin lispro in type 2 diabetes mellitus (T2DM), sponsored by Mount Sinai Hospital. Started Apr 2013; status: completed.
02
Drugs
insulin glargineinsulin lispro
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01755468.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01755468.